close

Process Analytical Platform for Autologous Cell-Based Therapy Manufacturing

A microchip-based process analytical technologies (PAT) platform tailored for autologous cell therapies (ACTs) manufacturing fulfilling the one patient - one batch paradigm will be developed.

https://www.aramis.admin.ch/Grunddaten/?ProjectID=56355

Kategorie

Innosuisse

Referenznummer

118.678 IP-LS

Projektstart

01.10.2024

Projektende

01.04.2026

Projektdauer

1 Year 6 Months

Projektstatus

laufend

Bereich

IMP-OST

A microchip-based process analytical technologies (PAT) platform tailored for autologous cell therapies (ACTs) manufacturing fulfilling the one patient - one batch paradigm will be developed.

https://www.aramis.admin.ch/Grunddaten/?ProjectID=56355

Personen

Dr.

Yves Mermoud

Projektverantwortlich
Zum Detail

Weitere Projekte dieser Hochschule

north